Edition:
United Kingdom

Genetic Technologies Ltd (GENE.OQ)

GENE.OQ on NASDAQ Stock Exchange Capital Market

1.10USD
14 Aug 2018
Change (% chg)

-- (--)
Prev Close
$1.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
63,925
52-wk High
$2.05
52-wk Low
$0.70

Chart for

About

Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women's health. The Company's lead product, BREVAGenplus, is a clinically validated risk assessment... (more)
No analyst recommendations are available for .

Overall

Beta: 2.64
Market Cap(Mil.): $15.14
Shares Outstanding(Mil.): 16.24
Dividend: --
Yield (%): --

Financials

  GENE.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.47 -- --
ROI: -74.37 1.78 14.61
ROE: -74.83 3.28 16.33

BRIEF-Genetic Technologies Enters Into A Non-Binding Terms Sheet With Omix Ventures Private ​

* ENTERED INTO A NON-BINDING TERMS SHEET WITH OMIX VENTURES PRIVATE ​

06 Mar 2018

BRIEF-Genetic Technologies Says H1 Comprehensive Loss Attributable $3.3 Mln

* H1 REVENUE FROM CONTINUING OPERATIONS - GENETIC TESTING SERVICES $97.8 MILLION VERSUS $369.1 MILLION

26 Feb 2018

Competitors

  Price Chg
Sonic Healthcare Limited (SHL.AX) $26.78 +0.53
Healthscope Ltd (HSO.AX) $2.12 -0.01

Earnings vs. Estimates